Guardant Health, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
T. Rowe Price Associates, Inc. has reported beneficial ownership of 5.4% of Guardant Health Inc.'s common stock as of March 31, 2026.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.02% of Guardant Health Inc.'s common stock as of March 31, 2026.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Guardant Health Inc. following an internal realignment.
NASDAQ
Deep Track Capital, LP and its affiliates have filed an amended Schedule 13G, disclosing a 4.41% beneficial ownership stake in Guardant Health, Inc. as of March 31, 2025.
NASDAQ
SCHEDULE 13G/A: BlackRock Maintains Significant 7.5% Stake in Guardant Health, Files Updated Beneficial Ownership Report
BlackRock, Inc. has filed an updated Schedule 13G, reaffirming its substantial passive ownership of 7.5% of Guardant Health, Inc.'s common stock as of March 31, 2025.
NASDAQ
Cadian Capital Management, LP, along with its general partner and managing member Eric Bannasch, has disclosed a beneficial ownership of 4.2% in Guardant Health, Inc. as of December 31, 2024.
NASDAQ
Wellington Management Group LLP and its affiliates have disclosed a 3.9% beneficial ownership stake in Guardant Health, Inc. as of December 31, 2024, through an amended Schedule 13G filing.